The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01598337
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 200 participants
- Sponsor
- Prince Sultan Cardiac Center, Adult Cardiology Department.
- Registry
-
NCT01598337
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- Saudi Arabia
- Registry status
- Unknown status
Technical summary
Registry record NCT01598337. Randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Tirofiban
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Prasugrel
- Lead sponsor
- Prince Sultan Cardiac Center, Adult Cardiology Department.
Record details
- Record id
cardio:ct-nct01598337- Content hash
0d7e365954395e7acd0e2c5879d1013c1de3f69bb38bc75185f6d4ada370c812